FEATURED INSIGHTS

• A Strategic Overview Of Fc Engineering

  Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges.

• APOEε4: Why Alzheimer's "Prophet" Struggles To Become A Therapeutic "Savior"

  Explore the technical hurdles of APOE-targeted development and the precision tools—including target proteins and pre-formed fibrils (PFFs)—required to bridge the gap from risk identification to commercial success.

• Mycoplasma Testing: Rapid Detection Accelerates Biopharmaceutical Release

  Learn how to implement a validated, broad-spectrum qPCR workflow that covers over 250 species, ensuring both regulatory compliance and accelerated speed-to-market for your clinical-grade products.

• Mycoplasma Detection: A Critical Defense For Ensuring Biopharmaceutical Quality

  Explore how integrated PCR-based workflows provide the specificity and speed necessary to safeguard your cell matrix and ensure regulatory compliance.

• Deep Interpretation Of GMP Product Quality

  Explore the critical aspects of GMP-grade raw materials in cell and gene therapy manufacturing, including contamination control, aseptic strategies, quality systems, supply chain security, and regulatory compliance.

• CAR Expression Detection Using Fluorescent Labeled Proteins, Flow Cytometry

  Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.

• High-Sensitivity Residual E. coli DNA Testing Supporting Biologics, CGT Development

  Advancements in high-sensitivity residual DNA testing enhance the precision of plasmid DNA purity analysis, ensuring compliance with regulatory standards critical for manufacturing processes.

• Developing A Scalable Protocol For T Cell Activation, Expansion

  Explore a scalable protocol for T cell activation and expansion, designed to enhance immunotherapy workflows. ​ This approach ensures robust T cell growth, viability, and memory phenotypes for clinical applications. 

• CD8+ Single Positive T Cell Differentiation From HiPSC With A Feeder-Free System In Vitro

  Learn about a feeder-free method to differentiate CD8+ single positive T cells from human induced pluripotent stem cells, which offers promising advancements for scalable and efficient cell therapies.

• Scalable iPSC Differentiation To Natural Killer Cells With Cytotoxic Potential

  Explore an innovative serum-free method to differentiate induced pluripotent stem cells (iPSCs) into natural killer (NK) cells, offering scalable solutions for immunotherapy with enhanced cytotoxic potential.

• Raw Materials Considerations When Manufacturing CGTs And Other Biologics

  Discover key considerations for qualifying GMP raw materials in cell and gene therapy manufacturing, emphasizing quality control, supplier selection, and regulatory compliance to ensure therapeutic safety and efficacy.